Statistical Primer on Biosimilar Clinical Development

por Isakov, Leah, Jin, Bo, Jacobs, Ira Allen
Publicado 2016

Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence

por Jacobs, Ira, Petersel, Danielle, Isakov, Leah, Lula, Sadiq, Lea Sewell, K.
Publicado 2016

Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis

por Simoens, Steven, Jacobs, Ira, Popovian, Robert, Isakov, Leah, Shane, Lesley G.
Publicado 2017

Comparability of Titers of Antibodies against Seasonal Influenza Virus Strains as Determined by Hemagglutination Inhibition and Microneutralization Assays

por Heeringa, Marten, Leav, Brett, Smolenov, Igor, Palladino, Giuseppe, Isakov, Leah, Matassa, Vincent
Publicado 2020

Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50–64 Years of Age

por Poder, Airi, Oberije, Janine, Meyer, Jay, Heymer, Peter, Molrine, Deborah, Versage, Eve, Isakov, Leah, Zhang, Qiuhong, Hohenboken, Matthew
Publicado 2023

A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates

por Berry, Donald A., Berry, Scott, Hale, Peter, Isakov, Leah, Lo, Andrew W., Siah, Kien Wei, Wong, Chi Heem
Publicado 2020